8-KItem 1.01 · Material AgreementItem 8.01 · Other EventsItem 9.01 · Financial Statements
Viatris to Acquire Pacira BioSciences for $1.65 Billion
Filed with the SEC on · Summarized by InvestorsBot
Viatris entered an agreement to acquire Pacira BioSciences for $36.50 per share in cash, representing an aggregate equity value of approximately $1.65 billion. Viatris will launch a tender offer followed by a merger, with Pacira’s board recommending the deal; completion requires majority shareholder tenders, regulatory clearance and other customary conditions, and is expected by the end of 2026.